Studien | Der Arzneimittelbrief

Action in Diabetes and Vascular disease - preterAx and diamicroN modified release Controlled Evaluation (3)

Literaturstellen

Nephrol.Dial.Transplant. 2012,27,3337
Am.J.Kidney Dis. 2012,60,770
Circulation 2013,128,1325; 2016,134,1637
Cancer Epidemiol.Biomarkers Prev. 2013,22,1628
Kidney Int. 2013,83,517
Diabetes Obes.Metab. 2013,15,1008; 2016,18,289; 2020,22,452; 1818; 2021,23,1420; 1775
Diabetes 2014,63,1115; 2021,70,255
J Open 2016,6,e009668
Value Health 2016,19,36
Cardiovasc.Drugs Ther. 2017,31,391; 2022,38,131
Clin.J.Am.Soc.Nephrol. 2019,14,862; 2022,17,1139
J.Clin.Transl.Sci. 2021,14,2193
Int.J.Cardiol. 2022,358,103
Cereb.Circ.Cogn.Behav. 2024,8,100372